JP2007516983A5 - - Google Patents

Download PDF

Info

Publication number
JP2007516983A5
JP2007516983A5 JP2006545846A JP2006545846A JP2007516983A5 JP 2007516983 A5 JP2007516983 A5 JP 2007516983A5 JP 2006545846 A JP2006545846 A JP 2006545846A JP 2006545846 A JP2006545846 A JP 2006545846A JP 2007516983 A5 JP2007516983 A5 JP 2007516983A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
compound
salt
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006545846A
Other languages
English (en)
Japanese (ja)
Other versions
JP5384793B2 (ja
JP2007516983A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2004/001830 external-priority patent/WO2005061513A1/en
Publication of JP2007516983A publication Critical patent/JP2007516983A/ja
Publication of JP2007516983A5 publication Critical patent/JP2007516983A5/ja
Application granted granted Critical
Publication of JP5384793B2 publication Critical patent/JP5384793B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006545846A 2003-12-24 2004-12-24 呼吸器合胞体ウイルス感染の処置のための多環式薬剤 Expired - Fee Related JP5384793B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2003907196 2003-12-24
AU2003907196A AU2003907196A0 (en) 2003-12-24 Polycyclic agents for the treatment of respiratory syncytial virus infections
PCT/AU2004/001830 WO2005061513A1 (en) 2003-12-24 2004-12-24 Polycyclic agents for the treatment of respiratory syncytial virus infections

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012204388A Division JP5536842B2 (ja) 2003-12-24 2012-09-18 呼吸器合胞体ウイルス感染の処置のための多環式薬剤

Publications (3)

Publication Number Publication Date
JP2007516983A JP2007516983A (ja) 2007-06-28
JP2007516983A5 true JP2007516983A5 (cg-RX-API-DMAC10.html) 2008-02-07
JP5384793B2 JP5384793B2 (ja) 2014-01-08

Family

ID=34705575

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006545846A Expired - Fee Related JP5384793B2 (ja) 2003-12-24 2004-12-24 呼吸器合胞体ウイルス感染の処置のための多環式薬剤
JP2012204388A Expired - Fee Related JP5536842B2 (ja) 2003-12-24 2012-09-18 呼吸器合胞体ウイルス感染の処置のための多環式薬剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012204388A Expired - Fee Related JP5536842B2 (ja) 2003-12-24 2012-09-18 呼吸器合胞体ウイルス感染の処置のための多環式薬剤

Country Status (16)

Country Link
US (2) US8598193B2 (cg-RX-API-DMAC10.html)
EP (2) EP1697377B1 (cg-RX-API-DMAC10.html)
JP (2) JP5384793B2 (cg-RX-API-DMAC10.html)
KR (1) KR20060127909A (cg-RX-API-DMAC10.html)
CN (2) CN101723949B (cg-RX-API-DMAC10.html)
AT (1) ATE496920T1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0418127A (cg-RX-API-DMAC10.html)
CA (1) CA2551178C (cg-RX-API-DMAC10.html)
DE (1) DE602004031258D1 (cg-RX-API-DMAC10.html)
ES (1) ES2360222T3 (cg-RX-API-DMAC10.html)
IL (1) IL176155A0 (cg-RX-API-DMAC10.html)
NO (1) NO20062758L (cg-RX-API-DMAC10.html)
NZ (1) NZ551468A (cg-RX-API-DMAC10.html)
RU (1) RU2422444C2 (cg-RX-API-DMAC10.html)
WO (1) WO2005061513A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200604528B (cg-RX-API-DMAC10.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060127909A (ko) 2003-12-24 2006-12-13 비오타 사이언티픽 매니지먼트 피티와이 엘티디 호흡기 다핵체 바이러스 감염 치료용 다환 물질
EP1966144A1 (en) * 2005-12-20 2008-09-10 Novartis AG Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
AU2007288245A1 (en) 2006-08-24 2008-02-28 Novartis Ag 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyrazol-3-yl) -thiazole derivatives as well as related compounds as stearoyl-CoA desaturase (SCD) inhibitors for the treatment of metabolic, cardiovascular and other disorders
CA2662574A1 (en) 2006-09-22 2008-03-27 Novartis Ag Heterocyclic organic compounds
TWI423972B (zh) * 2006-09-28 2014-01-21 Biota Scient Management 治療呼吸系融合細胞病毒感染之多環劑
EP2121671A1 (en) 2006-12-20 2009-11-25 Novartis AG 2-substituted 5-membered heterocycles as scd inhibitors
TWI508968B (zh) * 2010-02-08 2015-11-21 Biota Scient Management 用於治療呼吸道融合性病毒感染的化合物
HRP20160431T1 (hr) * 2010-06-24 2016-05-20 Gilead Sciences, Inc. Pirazolo[1,5-a]pirimidini i triazini kao antivirusni agensi
AU2015200638B2 (en) * 2010-06-24 2016-11-10 Gilead Sciences, Inc. Pyrazolo [1, 5 -a] pyrimidines as antiviral agents
US8796303B2 (en) 2010-11-26 2014-08-05 Biota Scientific Management Pty Ltd. Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections
US8871756B2 (en) * 2011-08-11 2014-10-28 Hoffmann-La Roche Inc. Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
ES2593059T3 (es) * 2011-10-11 2016-12-05 F. Hoffmann-La Roche Ag Compuestos para el tratamiento y profilaxis de enfermedad por virus sincitial respiratorio
CN103748098B (zh) * 2011-10-11 2016-06-29 弗·哈夫曼-拉罗切有限公司 用于治疗或预防呼吸道合胞病毒疾病的化合物
GB201119538D0 (en) 2011-11-10 2011-12-21 Viral Ltd Pharmaceutical compounds
EP2794611B1 (en) 2011-12-22 2017-10-11 Gilead Sciences, Inc. Pyrazolo[1,5-a]pyrimidines as antiviral agents
US8980878B2 (en) 2012-04-17 2015-03-17 Gilead Sciences, Inc. Compounds and methods for antiviral treatment
CN104311559A (zh) * 2014-09-12 2015-01-28 中山大学 一类光学纯手性环状n,n-缩醛的合成方法
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
WO2016133888A1 (en) * 2015-02-16 2016-08-25 Biota Pharmaceuticals, Inc. Compounds for treating respiratory syncytial virus infections
JO3637B1 (ar) 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
EP3298017B1 (en) 2015-05-20 2019-08-14 H. Hoffnabb-La Roche Ag Compounds for treating spinal muscular atrophy
CN108290882B (zh) 2015-07-16 2021-07-06 豪夫迈·罗氏有限公司 用于治疗呼吸道合胞病毒感染的4-喹唑啉胺衍生物的晶形
EP4360707A3 (en) 2015-11-12 2024-08-07 F. Hoffmann-La Roche AG Compositions for treating spinal muscular atrophy
HUE055031T2 (hu) 2015-12-10 2021-10-28 Ptc Therapeutics Inc Módszerek Huntington-kór kezelésére
JP6872550B2 (ja) 2015-12-10 2021-05-19 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 架橋されたピペリジン誘導体
CN109641042B (zh) * 2016-05-10 2023-06-09 乔治亚州立大学研究基金会股份有限公司 用于治疗rsv的杂环衍生物
JP7376471B2 (ja) 2017-06-05 2023-11-08 ピーティーシー セラピューティクス, インコーポレイテッド ハンチントン病を処置するための化合物
AU2018285412B2 (en) 2017-06-14 2022-06-23 Universität Zürich Cyclic peptides for protection against respiratory syncytial virus
CN111182898B (zh) 2017-06-28 2024-04-16 Ptc医疗公司 用于治疗亨廷顿氏病的方法
WO2019005993A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. METHODS OF TREATING HUNTINGTON'S DISEASE
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗rsv活性之吡唑并嘧啶
WO2019149734A1 (en) 2018-01-31 2019-08-08 Janssen Sciences Ireland Unlimited Company Cycloalkyl substituted pyrazolopyrimidines having activity against rsv
WO2019168874A1 (en) 2018-02-27 2019-09-06 The Research Foundation For The State University Of New York Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same
CN112135815A (zh) 2018-03-27 2020-12-25 Ptc医疗公司 用于治疗亨廷顿氏病的化合物
US11708369B2 (en) 2018-04-23 2023-07-25 Janssen Sciences Ireland Unlimited Company Heteroaromatic compounds having activity against RSV
MX2020012827A (es) 2018-06-05 2021-02-15 Hoffmann La Roche Compuestos tetrahidro-1h-pirazino[2,1-a]isoindolilquinolina para el tratamiento de enfermedades autoinmunes.
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
ES2983003T3 (es) 2018-06-27 2024-10-21 Ptc Therapeutics Inc Compuestos heterocíclicos y heteroarílicos para el tratamiento de la enfermedad de Huntington
MX2020014315A (es) 2018-06-27 2021-05-27 Ptc Therapeutics Inc Compuestos de heteroarilo para tratar la enfermedad de huntington.
CN108997354B (zh) * 2018-08-08 2021-12-31 青岛大学附属医院 二氢嘧啶并异吲哚酮类化合物及其乳膏剂和在治疗高尿酸血症中的用途

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1058529A (en) 1910-12-24 1913-04-08 Harry T Hickey Car-door.
NL137586C (cg-RX-API-DMAC10.html) 1963-04-11
US3507863A (en) 1963-12-18 1970-04-21 Sandoz Ag Isoindolones and method for preparing same
NL126596C (cg-RX-API-DMAC10.html) * 1964-02-11
CH480350A (de) 1965-09-21 1969-10-31 Geigy Ag J R Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen
NL129866C (cg-RX-API-DMAC10.html) * 1965-09-21
US3379733A (en) * 1965-12-07 1968-04-23 Sandoz Ag N-(omega-aminoalkyl)isoindoles and method for preparing same
CH481124A (de) * 1966-09-21 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen
JPS4939677B1 (cg-RX-API-DMAC10.html) 1967-03-14 1974-10-28
CH482697A (de) 1967-03-17 1969-12-15 Geigy Ag J R Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen
US3935218A (en) * 1968-09-05 1976-01-27 American Home Products Corporation Imidazolinyl phenyl carbonyl compounds acid addition salts and related compounds
US3885037A (en) * 1968-09-05 1975-05-20 American Home Prod Method of producing anorexia using imidazolinyl phenyl carbonyl compounds, their acid addition salts and related compounds
US3657221A (en) * 1969-02-19 1972-04-18 American Home Prod Process for preparing 9b-substituted-1 - sulfonyl - 1 2 3 9b - tetrahydro-5h-imidazo(2 1-a)isoindol-5-ones
GB1322339A (en) 1970-03-10 1973-07-04 American Home Prod Imidazoline derivatives
US3770766A (en) 1970-03-10 1973-11-06 American Home Prod 2-(2-amino-2,2-dialkylamino-3-hydroxy-3-phenyl-1h-benz(f)isoindole-1-ones
US3624101A (en) * 1970-03-10 1971-11-30 American Home Prod 2,3-DIHYDRO-5-ARYL-5H-BENZ{8 f{9 IMIDAZO{8 2,1-a{9 ISOINDOL-5-OLS
US3885307A (en) * 1972-05-01 1975-05-27 William A Papalardo Peeling utensil
US3966955A (en) * 1974-08-07 1976-06-29 American Home Products Corporation Anti-ulcer therapy
US4056536A (en) * 1976-06-29 1977-11-01 Merck & Co., Inc. Pyrrolo[2,1-b][3]benzazepines
US4258529A (en) * 1978-07-21 1981-03-31 Phillips Petroleum Company Method of sealing a container
US4701208A (en) * 1983-08-02 1987-10-20 American Cyanamid Company Dihydroimidazopyrrolopyridine, quinoline, thieno- and furo[2,3-b]pyridine, dihydrothieno- and furo[2,3-b]-pyridine, thieno- and furo[3,2-b]pyridine and dihydrothieno- and furo[3,2-b]pyridine herbicides and method for preparation thereof
DE3520390A1 (de) * 1984-07-07 1986-02-06 Bayer Ag, 5090 Leverkusen Imidazo-pyrrolo-pyridin-derivate
EP0183993A3 (de) 1984-11-16 1987-12-09 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 2H-Imidazo[1',2':1,2]pyrrolo[3,4-b]pyridine und deren Verwendung als Unkrautbekämpfungsmittel
DE3674028D1 (de) 1985-03-12 1990-10-18 Ciba Geigy Ag Heterocyclisch kondensierte pyridin-verbindungen als herbizide.
DE3534948A1 (de) * 1985-10-01 1987-04-09 Bayer Ag Fungizide und wachstumsregulatorische mittel
US4717414A (en) * 1986-08-08 1988-01-05 Ppg Industries, Inc. Herbicidally active imidazopyrrolo-pyridine (or benzene) derivatives
DE3634952A1 (de) * 1986-10-14 1988-04-21 Bayer Ag Imidazo-pyrrolo-pyridin-derivate
EP0475908A1 (de) * 1990-09-14 1992-03-18 Ciba-Geigy Ag Chromogene Lactamverbindungen und ihre Herstellung und Verwendung
DE4103177A1 (de) 1991-02-02 1992-08-06 Boehringer Mannheim Gmbh Thiazolo-(2,3-a)isoindol-derivate und diese enthaltende arzneimittel
CA2104963A1 (en) 1991-02-28 1992-08-29 Harald Zilch Use of tricyclic isoindolinones as anti-viral medicaments as well as new optically-active isoindolinones
DE4108395A1 (de) 1991-03-15 1993-01-28 Boehringer Mannheim Gmbh Verwendung von oxazolo-(2,3-a)isoindol-und imidazo(2,1-a)-isoindol-derivaten als antivirale arzneimittel sowie neue oxazolo(2,3-a)isoindol-derivaten
DE4129779A1 (de) * 1991-09-07 1993-03-11 Boehringer Mannheim Gmbh Neue tricyclische thiazol- und oxazol-derivate und diese enthaltende arzneimittel
ATE316089T1 (de) * 1999-08-25 2006-02-15 Banyu Pharma Co Ltd Isoindolderivate
US6489338B2 (en) * 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) * 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
AU2002223275A1 (en) 2000-11-22 2002-06-03 Biota Scientific Management Pty Ltd A method of expression and agents identified thereby
WO2002066479A1 (en) * 2001-02-23 2002-08-29 Banyu Pharmaceutical Co.,Ltd. Novel isoindole derivatives
JP2002310962A (ja) * 2001-04-19 2002-10-23 Hitachi Ltd 画像分類方法並びに観察方法及びその装置
AUPR878401A0 (en) 2001-11-09 2001-12-06 Biota Holdings Ltd Methods for identifying or screening anti-viral agents
KR20060127909A (ko) 2003-12-24 2006-12-13 비오타 사이언티픽 매니지먼트 피티와이 엘티디 호흡기 다핵체 바이러스 감염 치료용 다환 물질
ES2567197T3 (es) 2005-04-28 2016-04-20 Viiv Healthcare Company Derivado de carbamoilpiridona policíclico que tiene actividad inhibidora de la integrasa del VIH
TWI423972B (zh) 2006-09-28 2014-01-21 Biota Scient Management 治療呼吸系融合細胞病毒感染之多環劑

Similar Documents

Publication Publication Date Title
JP2007516983A5 (cg-RX-API-DMAC10.html)
RU2006126663A (ru) Полициклические средства для лечения респираторно-синцитиальных вирусных инфекций
JP2010536887A5 (cg-RX-API-DMAC10.html)
JP2012512886A5 (cg-RX-API-DMAC10.html)
JP2006502119A5 (cg-RX-API-DMAC10.html)
HRP20090673T1 (hr) Derivati kvinolina i njihova uporaba kao mikobakterijskih inhibitora
SA99200059A (ar) مركبات إميدازول جديدة مستبدلة
CA2548654A1 (en) Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
JP2007529479A (ja) マラリアの治療及び予防を意図する医薬品を調製するためのインダゾールカルボキサミド誘導体の使用
JP2012507566A5 (cg-RX-API-DMAC10.html)
JP2012532112A5 (cg-RX-API-DMAC10.html)
JP2006509749A5 (cg-RX-API-DMAC10.html)
JP2017537949A5 (cg-RX-API-DMAC10.html)
JP2007508358A5 (cg-RX-API-DMAC10.html)
CA2554049A1 (en) Quinoline derivatives for use as mycobacterial inhibitors
WO2004083167A1 (ja) スルファミド誘導体及びその医薬組成物
JP2013544860A5 (cg-RX-API-DMAC10.html)
JP2016508135A5 (cg-RX-API-DMAC10.html)
JP2005538111A5 (cg-RX-API-DMAC10.html)
JP2007538031A5 (cg-RX-API-DMAC10.html)
JP2005505583A5 (cg-RX-API-DMAC10.html)
AU2007302611C1 (en) Polycyclic agents for the treatment of respiratory syncytial virus infections
JP2006528667A5 (cg-RX-API-DMAC10.html)
JP2018522915A5 (cg-RX-API-DMAC10.html)
KR101536488B1 (ko) 이미다졸 유도체, 그의 제조 방법 및 용도